ACB $12.270 (0%)

ACNNF $0.099 (-5.13%)

AERO $3.490 (0.29%)

AGEEF $0.087 (8.38%)

ALEAF $0.365 (0.01%)

AMMJ $0.120 (-3.61%)

APHA $4.300 (-1.38%)

ARNA $63.100 (1.01%)

ATT:CNX $0.080 (0%)

ATTBF $0.009 (1.16%)

AUSA:CNX $0.175 (-14.63%)

AUSAF $0.150 (-7.63%)

AVXL $4.950 (-1%)

BAMM:CNX $0.385 (0%)

BBM:CNX $0.055 (-8.33%)

BBRRF $0.045 (-13.12%)

BE:CNX $0.005 (0%)

BIO:CNX $0.060 (9.09%)

BLEVF $0.002 (-68.57%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.390 (-6.02%)

BLOZF $0.300 (-3.07%)

BUDZ $0.271 (0.19%)

BXNG $0.610 (0%)

CADMF $0.510 (8.83%)

CALI:CNX $0.080 (0%)

CANN $0.432 (-0.69%)

CARA $17.520 (-1.02%)

CBII:CNX $0.100 (0%)

CBIIF $0.068 (-2.86%)

CBWTF $0.211 (-4.93%)

CGC $16.450 (-0.12%)

CGRW $0.092 (-8.41%)

CHOO:CNX $0.145 (0%)

CHOOF $0.106 (2.02%)

CNBX $0.244 (2.53%)

CNGGF $0.645 (9.15%)

CODI $17.080 (2.46%)

CPMD $1.010 (1%)

CRBP $7.950 (-5.24%)

CRON $6.170 (0.98%)

CROP:CNX $0.015 (0%)

CRTPF $1.670 (-3.47%)

CRXPF $0.030 (0%)

CSI:CNX $0.770 (4.05%)

CURR $1.860 (5.08%)

CVSI $0.602 (-1.39%)

DIGP $0.039 (-2.26%)

DXBRF $0.140 (0%)

EAPH $0.001 (0%)

EAT:CNX $0.030 (0%)

EEVVF $0.046 (-8%)

EMHTF $0.131 (-6.61%)

EPWCF $0.047 (16%)

EVIO $0.019 (-10.63%)

FFRMF $0.032 (3.23%)

FFT:CNX $0.045 (12.5%)

FNNZF $0.066 (1.38%)

GGTTF $0.116 (3.57%)

GLDFF $0.013 (-15.31%)

GLH:CNX $0.020 (0%)

GNBT $0.599 (-4.24%)

GRIN:CNX $0.160 (0%)

GRWG $6.800 (-1.16%)

GSTR:CNX $0.070 (0%)

GTBIF $10.000 (-1.86%)

GTII:CNX $13.500 (-0.44%)

GWPH $125.350 (-0.67%)

HEXO $0.723 (-2.3%)

HHPHF $0.015 (0%)

HLSPY $0.425 (0.59%)

HMLSF $5.041 (3.52%)

HMPPF $0.498 (0%)

HRVOF $0.065 (7.92%)

HSTRF $0.076 (1.33%)

HUGE:CNX $5.010 (-1.18%)

IAN:CNX $0.305 (0%)

IGC $0.561 (-0.43%)

IGXT $0.209 (2.5%)

IIPR $92.790 (-1.03%)

IMLFF $0.193 (-0.39%)

INQD $0.004 (-5.13%)

IONC:CNX $0.015 (0%)

IONKF $0.011 (-16.21%)

ISOL:CNX $0.065 (0%)

ISOLF $0.046 (-10.18%)

ITHUF $0.185 (-0.8%)

IVITF $0.022 (-15.38%)

JWCAF $0.004 (0%)

KALTF $0.015 (0%)

KBEV:CNX $0.075 (-6.25%)

KBEVF $0.062 (7.23%)

KHRNF $0.421 (0.31%)

KSHB $0.745 (-3.56%)

LHS:CNX $0.485 (3.19%)

LHSIF $0.349 (-1.55%)

LOVE:CNX $0.110 (4.76%)

LXRP $0.295 (-3.39%)

LXX:CNX $0.390 (-1.27%)

MCIG $0.027 (-1.85%)

MEDIF $0.915 (6.45%)

MGWFF $0.065 (-6.38%)

MICWF $0.058 (0%)

MJ:CNX $0.045 (0%)

MJNA $0.017 (-5.56%)

MNTR $0.095 (-4.8%)

MRRCF $0.005 (0%)

MWM:CNX $0.205 (0%)

MYM:CNX $0.075 (0%)

MYMMF $0.052 (-6.31%)

NCNNF $0.154 (-3.57%)

NDVAF $0.220 (8.25%)

NGW:CNX $0.135 (8%)

NRXCF $0.048 (-6.08%)

NSPDF $0.043 (6.25%)

NTEC $0.282 (-7.15%)

NVTQF $0.099 (0%)

NWKRF $0.424 (0%)

NXGWF $0.103 (-7.06%)

NXTTF $0.258 (5.47%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.012 (2.5%)

PHCG $0.400 (0%)

PHVAF $0.060 (-3.23%)

PILL:CNX $0.850 (6.25%)

PKG:CNX $0.095 (0%)

PLPRF $0.481 (-3.8%)

PLUS:CNX $0.620 (-6.06%)

PMCB $0.024 (-4.86%)

PNPL $0.080 (0%)

POTN $0.012 (-7.98%)

PRCNF $0.009 (0%)

PTNYF $0.076 (-0.13%)

QCA:CNX $0.110 (4.76%)

RDDTF $0.114 (-5.79%)

RLLVF $0.021 (0%)

RMHB $0.025 (-2.31%)

RQB:CNX $0.005 (0%)

RQHTF $0.200 (0%)

RVVQF $0.016 (21.54%)

SLNG:CNX $0.175 (-2.78%)

SMG $134.670 (0.88%)

SNN:CNX $0.155 (0%)

SNNVF $0.120 (0%)

SOL:CNX $0.470 (2.17%)

SOLCF $0.326 (-6.83%)

SPLIF $0.023 (-10.3%)

SPRWF $0.184 (-0.43%)

SRNA $0.028 (-0.88%)

STEM:CNX $0.620 (0%)

STMH $0.480 (-2.04%)

SUN:CNX $0.160 (0%)

TBPMF $0.154 (-0.07%)

TCAN:CNX $1.030 (3%)

TCNAF $0.693 (-0.89%)

TER:CNX $3.090 (6.19%)

TGEN $0.725 (2.88%)

TGIF:CNX $0.075 (0%)

TGIFF $0.059 (-7.81%)

THC:CNX $0.190 (2.7%)

THCBF $0.137 (-2.14%)

TLRY $6.960 (-0.71%)

TOKI:CNX $0.045 (0%)

TRLFF $0.034 (6.9%)

TRPX $0.317 (0%)

TRSSF $2.150 (-4.02%)

TRTC $0.112 (-2.18%)

TURV $0.094 (0%)

VBIO $0.060 (0%)

VIDA:CNX $0.075 (-6.25%)

VIN:CNX $0.030 (20%)

VPRB $0.032 (10.03%)

VRNDF $0.410 (-1.23%)

VRT:CNX $0.170 (0%)

VRTHF $0.118 (-3.04%)

VVCIF $0.173 (-3.89%)

WAYL:CNX $0.740 (0%)

WDDMF $0.350 (-5.1%)

WLDFF $0.123 (2.24%)

XXII $0.737 (-2.11%)

ZDPY $0.131 (0%)

ZYNE $3.500 (-5.53%)

Technical420 Site Search

Returned 406 result(s).

GW Pharmaceuticals Presents Nabiximols U.S. Development and Commercial Strategy

GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announces the Company’s strategy for bringing its pipeline product nabiximols to the U.S. market. This strategy includes multiple opportunities for the submission of an initial…

Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced top line results from the 14-week pivotal CONNECT-FX (Clinical study of Cannabidiol (CBD) in Children and Adolescents with Fragile X) trial. The multi-national, randomized, double-blind, placebo-controlled trial assessed the efficacy…

Is Big Money Coming Back Into The CBD Sector?

During the last year, the cannabidiol (CBD) industry has been under pressure and we believe that the market has become saturated with new brands. In early 2019, several CBD companies were being assigned unicorn valuations ($1+ billion) as investors piled into these businesses. The CBD sector was driven higher by…

Oxford Investments Holdings Inc.: Pioneer Green Farms Commences Florida Hemp Cultivation

Oxford Investments Holdings Inc. (OTC Pink: OXIHF) ("Oxford" or the "Company") is pleased to announce that its Florida-based subsidiary, Pioneer Green Farms LLC. ("Pioneer Green"), has commenced hemp cultivation operations in Florida. Drymon's Citrus Nursery ("Drymon's") of Sarasota, Florida, has been granted a hemp cultivation license by the Florida Department…

Is Now The Time To Put Some Faith Back In Aurora Cannabis?

The last few weeks have been eventful for Aurora Cannabis Inc. (ACB.TO) (ACB) and this is a trend that our readers should be aware of. After completing a reverse split, the Canadian cannabis producer came under heavy pressure and the shares touched new 52-week lows. Shortly after the decline, Aurora…

The Safe Banking Act Is Once Again On Its Way To The Senate

2020 has been a challenging year for the global economy as COVID-19 has forced businesses to shut down in order to slow down the spread of the virus. One of the most interesting developments that is associated with COVID-19 is the classification of businesses as essential or non-essential. The cannabis…

Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform

Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, and Reliva, LLC ("Reliva") a leader in the sale of hemp-derived CBD products in the United States, are pleased to announce that they have entered into an agreement  pursuant to…

What Happened To The Hemp Boom??????

Although demand for hemp and cannabidiol (CBD) products has not been too impacted by the COVID-19 outbreak, the sector has not lived up to expectations. Companies that were considered to be leaders in the hemp-CBD industry have been forced to shutter operation or file for bankruptcy. During the last year,…

Emerald Organic Products Is A Multifaceted Healthcare Company Investors Should Be Watching

Last month, we published an article that highlighted Emerald Organic Products, Inc. (OTC: EMOR) and received a lot of positive feedback on the opportunity. We believe that Emerald Organic Products represents an emerging diversified health sciences company that is focused on a number of high-growth verticals and is flying under…

Cardiol Therapeutics To Benefit On The Rescheduling Of GW Pharma’s Epidiolex By The DEA

Earlier this year, the Drug Enforcement Administration (DEA) announced a significant development for patients who need to access Epidiolex, the only federally approved drug derived from cannabis. Epidiolex is manufactured and sold by GW Pharmaceuticals (GWPH) and is no longer considered to be a controlled substance under the Controlled Substances…

Older Posts »

Search Again